	US 11,911,420 B2
	*Prophylactic and/or therapeutic agents for Streptococcus pneumoniae* infection**
Susumu Kawaguchi, Yokkaichi (JP); and Miho Kato, Yokkaichi (JP)
Assigned to NUTRI CO., LTD., Yokkaichi (JP)
Appl. No. 16/962,921
Filed by Nutri Co., Ltd., Yokkaichi (JP)
PCT Filed Jan. 31, 2019, PCT No. PCT/JP2019/003296 § 371(c)(1), (2) Date Jul. 17, 2020, PCT Pub. No. WO2019/151371, PCT Pub. Date Aug. 8, 2019.
Claims priority of application No. 2018-015333 (JP), filed on Jan. 31, 2018.
Prior Publication US 2021/0379124 A1, Dec. 9, 2021
Int. Cl. A61K 35/744 (2015.01); A61P 31/04 (2006.01)

CPC A61K 35/744 (2013.01) [A61P 31/04 (2018.01)]

11 Claims

1. A method for treatment of Streptococcus pneumoniae infection, comprising orally administering to a subject a pharmaceutically effective amount of killed Enterococcus faecalis, strain EF-2001.